Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

September 27-28, 2023

7th International Conference on Biochemistry & Molecular Biology

Paris, France
October 02-03, 2023

22nd International Conference on Structural Biology

London, UK
October 30-31, 2023

4th International Conference on Polymer Waste - Biopolymers & Bioplastics

Rome, Italy
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy
November 01-02, 2023

19th International Conference on Metabolomics

Rome, Italy
February 13-14, 2024

20th International Conference on Metabolomics & Systems Biology

Barcelona, Spain
March 14-15, 2024

17th International Conference on Biosimilars and Pharmaceuticals

London, UK
May 16-17, 2024

16th International Conference on Tissue Science and Regenerative Medicine

Rome, Italy

Diagnostic Biomarkers in Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in